Continuous Neuromuscular Blockade for Bronchopulmonary Dysplasia
Conclusion In this case series of infants with severe BPD, there were no survivors among those receiving ≥25 days of CNMB. Linear growth, an essential growth parameter for infants with BPD, decreased in most patients. These data do not support the use of ≥25 days of CNMB to prevent mortality in infants with severe BPD.
Key Points
[...] Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USAArticle in Thieme eJournals: Table of contents | Abstract | Full text
Source: American Journal of Perinatology - Category: Perinatology & Neonatology Authors: Johnson, Emily D. Keppel, Kristopher McNamara, LeAnn Collaco, Joseph M. Boss, Renee D. Tags: Original Article Source Type: research
More News: Brain | Bronchopulmonary Dysplasia | Children | Intensive Care | Neurology | Pediatrics | Perinatology & Neonatology | Study